BREAKING NEWS

BREAKING NEWS

Shire delivers third-quarter earnings beat, reiterates guidance

Now Reading:

Shire delivers third-quarter earnings beat, reiterates guidance

Text size Aa Aa

LONDON (Reuters) – London-listed pharmaceutical firm Shire <SHP.L> reported a 20 percent rise in third-quarter earnings, beating market expectations, driven by growth in its immunology franchise. The company posted non-GAAP earnings per share, its preferred measure, of $3.81 on total revenue of $3.70 billion(£2.83 billion) on Friday, and reiterated its guidance for the year. Analysts on average expected the company to report earnings per share of $3.69 on revenue of $3.75 billion for the third quarter. ​

(Reporting by Paul Sandle; editing by Kate Holton)
euronews provides breaking news articles from reuters as a service to its readers, but does not edit the articles it publishes. Articles appear on euronews.com for a limited time.